SVRA stock

Savara Inc (SVRA) stock forecast · $1.11B cap

Savara Inc (SVRA) is a biotechnology company listed on NASDAQ.

This SVRA forecast page states what the cached financials imply — not a price target and not a guarantee. Savara Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.

No cached income statement for SVRA yet, so there is no numeric 2026 base to extend.

Period-over-period revenue change is not in cache for SVRA, so this page does not invent a growth rate.

SVRA currently screens at market cap $1.11B. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.

When the next SVRA 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.

Not a prediction market. For the live quote and the full model, use the SVRA stock page.

Not investment advice.

Full SVRA analysis